Effect of Phototherapy on Serum Calcium

Status Completed

Clinical Trial Summary

Through this study our aim was to evaluate whether significant change in serum calcium level occurs in term newborns who are undergoing phototherapy and to find out the association between effect of phototherapy on serum calcium level and birth weight, postnatal age and type of feeding.

Clinical Trial Description

Jaundice is the yellow discoloration of skin, sclerae, and other tissues caused by the deposition of bilirubin. Approximately 60% of term and 80% of preterm babies develop jaundice in the first week of life, and about 10% of breastfed babies are still jaundiced at 1 month. Jaundice is a common cause of readmission to hospital after early discharge of newborn infants. The most common form of hyperbilirubinaemia observed in neonates is due to unconjugated or unbound bilirubin. High levels of unconjugated bilirubin are managed by treatment of the underlying cause (e.g. dehydration and sepsis), provision of phototherapy, administration of immunoglobulin (in certain cases of haemolytic anaemia) and, in very severe cases, exchange transfusion. If left untreated, extreme elevation of unconjugated bilirubin can lead to permanent brain damage (kernicterus) and/or death. However, exchange transfusion is associated with a significant morbidity, and even mortality while phototherapy has several disadvantages which include increasing the duration of hospitalization, costs and mother-child separation . It also has some reported side effects as rash, loose green stools, dehydration, ocular hazards, oxidative injury, hyperthermia and water loss and may be associated with some long-term side effects such as melanocytic nevi, skin cancer, allergic disease, patent ductus arterious and retinal damage . Some studies are available concerning the prevalence of hypocalcemia in neonates after phototherapy, but the results varied based on where the studies were conducted. So, more studies were required to reach a definite conclusion. Through this study our aim was to evaluate whether significant change in serum calcium level occurs in term newborns who are undergoing phototherapy and to find out the association between effect of phototherapy on serum calcium level and birth weight, postnatal age and type of feeding. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04215601
Study type	Observational [Patient Registry]
Source	Assiut University
Contact
Status	Completed
Phase
Start date	February 1, 2020
Completion date	February 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03566186` - Effects of Phototherapy Associated With Sprint and Squat Training on Cardiac Autonomic Modulation	N/A
Recruiting	`NCT05556811` - HEaling LIght Algorithms for the ICU Patient	N/A
Recruiting	`NCT03384342` - Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo	N/A
Withdrawn	`NCT01818154` - Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)	N/A
Completed	`NCT03420391` - PBMT on Muscular Performance and Recovery in Different Time-points	N/A
Completed	`NCT03942757` - BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
Completed	`NCT04407351` - Develop Novel Phototherapy for Health Care of Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia	N/A
Completed	`NCT03752645` - Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only.	N/A
Completed	`NCT03570775` - Effectiveness, Safety and Perceptions With the Use of One LED Sleeping Bag Device in the Treatment of Neonatal Jaundice	N/A
Completed	`NCT03569254` - Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Jaundice	N/A
Recruiting	`NCT06110520` - Violet Light for the Suppression of Myopia	N/A
Recruiting	`NCT05949827` - Healing Light Algorithms for Nurses in the ICU
Completed	`NCT03695458` - Local and Systemic Effects of Photobiomodulation Therapy on Muscle Performance and Recovery Post-exercise.	N/A
Completed	`NCT03728439` - Effects of Light Emitting Diodes (LED) Therapy in Rugby Athletes	N/A
Enrolling by invitation	`NCT04636242` - Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.